BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34338690)

  • 1. Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum.
    Lusk H; Burdette JE; Sanchez LM
    Mol Omics; 2021 Dec; 17(6):819-832. PubMed ID: 34338690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Many Microenvironments of Ovarian Cancer.
    Micek HM; Visetsouk MR; Fleszar AJ; Kreeger PK
    Adv Exp Med Biol; 2020; 1296():199-213. PubMed ID: 34185294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex Vivo Ovarian Culture to Model the Initial Metastasis in Ovarian Cancer.
    Dean M
    Methods Mol Biol; 2022; 2424():189-198. PubMed ID: 34918296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.
    Bergsten TM; Burdette JE; Dean M
    Cancer Lett; 2020 Apr; 476():152-160. PubMed ID: 32067992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade serous ovarian cancer arises from fallopian tube in a mouse model.
    Kim J; Coffey DM; Creighton CJ; Yu Z; Hawkins SM; Matzuk MM
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3921-6. PubMed ID: 22331912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology.
    Brown Y; Hua S; Tanwar PS
    Matrix Biol; 2023 Apr; 118():16-46. PubMed ID: 36781087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging Mass Spectrometry Reveals Crosstalk between the Fallopian Tube and the Ovary that Drives Primary Metastasis of Ovarian Cancer.
    Zink KE; Dean M; Burdette JE; Sanchez LM
    ACS Cent Sci; 2018 Oct; 4(10):1360-1370. PubMed ID: 30410974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
    Karst AM; Levanon K; Drapkin R
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7547-52. PubMed ID: 21502498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 10. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
    El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
    Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the extracellular matrix remodeling of high-grade serous ovarian cancer with nonlinear optical microscopy.
    Yan J; Zhao Y; Lin F; Qu J; Liu Q; Pan Y; Liu L
    J Biophotonics; 2021 Jun; 14(6):e202000498. PubMed ID: 33624930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.
    Zhang L; Fu R; Liu P; Wang L; Liang W; Zou H; Jia W; Tao L
    J Ovarian Res; 2021 Nov; 14(1):149. PubMed ID: 34736492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
    Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
    Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer.
    Auer K; Bachmayr-Heyda A; Aust S; Grunt TW; Pils D
    Cancer Lett; 2017 Mar; 388():158-166. PubMed ID: 27940126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.
    Coan M; Rampioni Vinciguerra GL; Cesaratto L; Gardenal E; Bianchet R; Dassi E; Vecchione A; Baldassarre G; Spizzo R; Nicoloso MS
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Origins of High-Grade Serous Ovarian Cancer.
    Kim J; Park EY; Kim O; Schilder JM; Coffey DM; Cho CH; Bast RC
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30424539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer.
    Bergsten TM; Levy SE; Zink KE; Lusk HJ; Pergande MR; Cologna SM; Burdette JE; Sanchez LM
    Front Cell Dev Biol; 2022; 10():1042734. PubMed ID: 36420136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High grade serous ovarian carcinomas originate in the fallopian tube.
    Labidi-Galy SI; Papp E; Hallberg D; Niknafs N; Adleff V; Noe M; Bhattacharya R; Novak M; Jones S; Phallen J; Hruban CA; Hirsch MS; Lin DI; Schwartz L; Maire CL; Tille JC; Bowden M; Ayhan A; Wood LD; Scharpf RB; Kurman R; Wang TL; Shih IM; Karchin R; Drapkin R; Velculescu VE
    Nat Commun; 2017 Oct; 8(1):1093. PubMed ID: 29061967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
    Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.